Arrowhead PharmaceuticalsARWR 
$21.86-1.26%24h
-1.26%24h
Global rank4341
Market cap$2.33B
Change 7d-7.65%
YTD Performance-28.33%
SP500 benchmarkUnderperform
P/E-11.39
P/S9.69
Revenue$240.74M
Earnings-$209.28M
Dividend yield-
Main Sector
Healthcare
Arrowhead Pharmaceuticals ARWR Total Debt
ARWR Total Debt in 2022: $104.61M
According to Arrowhead Pharmaceuticals latest financial reports the total debt is $104.61M, an increase of 32.75% to 2022. At the end of 2022 company had $78.80M total debt. This figure represents the debts and financial obligations that Arrowhead Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Arrowhead Pharmaceuticals ARWR Total Debt History from 2023 to 2022
-
Value:-
ARWR Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $104.61M | 32.75% |
| 2022 | $78.80M | 238.27% |
| 2021 | $23.30M | 16.23% |
| 2020 | $20.04M | - |
| 2018 | $2.10M | - |
View the Top Total Debt Stocks 
